Werner Lanthaler
Directeur/Bestuurslid bij AC IMMUNE SA
Vermogen: 15 M $ op 31-05-2024
Profiel
Momenteel is Werner Lanthaler Chief Executive Officer bij Evotec SE. Hij is ook lid van de raad van bestuur van AC Immune SA, argenx SE, Evotec (UK) Ltd. en Topas Therapeutics GmbH (voormalig voorzitter van de raad van toezicht). In zijn vorige carrière bekleedde Dr. Lanthaler de functie van Chief Financial Officer voor Intercell AG. Hij behaalde een doctoraat en een bachelor diploma aan de Universiteit van Wenen en een graduaat diploma aan de Harvard University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
EVOTEC SE
0.85% | 31-12-2022 | 1 514 826 ( 0.85% ) | 14 M $ | 31-05-2024 |
AC IMMUNE SA
0.12% | 01-03-2024 | 123 184 ( 0.12% ) | 572 806 $ | 31-05-2024 |
ARGEN-X SE
0.00% | 20-02-2024 | 600 ( 0.00% ) | 221 918 $ | 31-05-2024 |
Actieve functies van Werner Lanthaler
Bedrijven | Functie | Begin |
---|---|---|
AC IMMUNE SA | Directeur/Bestuurslid | 06-07-2018 |
Evotec (UK) Ltd.
Evotec (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (UK) Ltd. provides research and development on natural sciences and engineering. The company is based in Abingdon, UK and was founded in 1991. | Directeur/Bestuurslid | 19-03-2009 |
Evotec (Hamburg) GmbH
Evotec (Hamburg) GmbH Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (Hamburg) GmbH provides companies with administration and management services. The company is based in Hamburg, Germany. The CEO of the German company is Ralph Enno Spillner. | Algemeen Directeur | - |
Eerdere bekende functies van Werner Lanthaler
Bedrijven | Functie | Einde |
---|---|---|
EVOTEC SE | Algemeen Directeur | 03-01-2024 |
ARGENX SE | Directeur/Bestuurslid | 27-02-2023 |
Topas Therapeutics GmbH
Topas Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Topas Therapeutics GmbH engages in pharmaceutical preparations. The company is headquartered in Hamburg, Germany. | Voorzitter | - |
Pantec Biosolutions AG
Pantec Biosolutions AG Drugstore ChainsRetail Trade Pantec Biosolutions AG provides laser microporation based transdermal drug delivery services. Its technology can be used for transdermal delivery, intradermal delivary, epidermal delivery, infertility patches, and aesthetic dermatology. The company was founded by Christof Böhler, Herbert Zech, Reinhard Braun, Werner Braun, and Thomas Bragagna in 2006 and is headquartered in Ruggell, Liechtenstein. | Directeur/Bestuurslid | 01-01-2013 |
DeveloGen AG
DeveloGen AG Pharmaceuticals: MajorHealth Technology DeveloGen AG is a biopharmaceutical company engaged in the discovery and development of novel therapeutics for the treatment of metabolic and endocrine disorders with a particular focus on diabetes. DeveloGen develops highly innovative approaches for the treatment of diabetes and obesity targeting key pathophysiological mechanisms such as insulin resistance and loss of insulin-producing beta cells. DeveloGen's product pipeline includes two programs at advanced stages of lead optimization, a small molecule inhibitor program based on a novel and proprietary target to address insulin resistance (type 2 diabetes). A growth factor targeting beta cell regeneration (type 1 and type 2 diabetes). DeveloGen is based in Goettingen, Germany. | Directeur/Bestuurslid | 25-01-2012 |
Opleiding van Werner Lanthaler
University of Vienna | Doctorate Degree |
Harvard University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
EVOTEC SE | Health Technology |
ARGENX SE | Health Technology |
AC IMMUNE SA | Health Technology |
Bedrijven in privébezit | 8 |
---|---|
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | Health Technology |
DeveloGen AG
DeveloGen AG Pharmaceuticals: MajorHealth Technology DeveloGen AG is a biopharmaceutical company engaged in the discovery and development of novel therapeutics for the treatment of metabolic and endocrine disorders with a particular focus on diabetes. DeveloGen develops highly innovative approaches for the treatment of diabetes and obesity targeting key pathophysiological mechanisms such as insulin resistance and loss of insulin-producing beta cells. DeveloGen's product pipeline includes two programs at advanced stages of lead optimization, a small molecule inhibitor program based on a novel and proprietary target to address insulin resistance (type 2 diabetes). A growth factor targeting beta cell regeneration (type 1 and type 2 diabetes). DeveloGen is based in Goettingen, Germany. | Health Technology |
BioXell SpA
BioXell SpA BiotechnologyHealth Technology BioXell SpA provides medical services. The company researches and develops drugs to treat urological, inflammatory, and related disorders. The company was founded in 2002 and is headquartered in Segrate, Italy. | Health Technology |
Pantec Biosolutions AG
Pantec Biosolutions AG Drugstore ChainsRetail Trade Pantec Biosolutions AG provides laser microporation based transdermal drug delivery services. Its technology can be used for transdermal delivery, intradermal delivary, epidermal delivery, infertility patches, and aesthetic dermatology. The company was founded by Christof Böhler, Herbert Zech, Reinhard Braun, Werner Braun, and Thomas Bragagna in 2006 and is headquartered in Ruggell, Liechtenstein. | Retail Trade |
Topas Therapeutics GmbH
Topas Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Topas Therapeutics GmbH engages in pharmaceutical preparations. The company is headquartered in Hamburg, Germany. | Health Technology |
Federation of Austrian Industry
Federation of Austrian Industry Miscellaneous Commercial ServicesCommercial Services The Federation of Austrian Industry is an organization that focuses on the observation and analysis of international developments, trade and investment agreements, and the conditions of fair international competition. The non-profit company is based in Vienna, Austria. Austria is a small but highly export-oriented economy, and the organization believes that for the future growth and prosperity of the country, its companies must have the best possible framework to take advantage of their international opportunities. The organization emphasizes the importance of sustainable international relationships and free and fair trade to ensure Austria's export capability and access to markets. The CEO of the Austrian company is Martin Ohneberg. | Commercial Services |
Evotec (UK) Ltd.
Evotec (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (UK) Ltd. provides research and development on natural sciences and engineering. The company is based in Abingdon, UK and was founded in 1991. | Commercial Services |
Evotec (Hamburg) GmbH
Evotec (Hamburg) GmbH Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (Hamburg) GmbH provides companies with administration and management services. The company is based in Hamburg, Germany. The CEO of the German company is Ralph Enno Spillner. | Commercial Services |